Allena Pharmaceuticals Cash and Cash Equivalents 2011-2026 | ALNA

Annual Cash and Cash Equivalents Allena Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
30 M	35 M	30 M	61.6 M	94.5 M	25.2 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
94.5 M	25.2 M	46.1 M

Quarterly Cash and Cash Equivalents Allena Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	6.59 M	8.9 M	30 M	40.4 M	26.7 M	36.3 M	35 M	35 M	35 M	35 M	30 M	30 M	30 M	30 M	61.6 M	61.6 M	61.6 M	61.6 M	94.5 M	94.5 M	94.5 M	94.5 M	25.2 M	25.2 M	-	-	69 M	-	-	-	26.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
94.5 M	6.59 M	45.4 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	170 M	$ 21.69	1.31 %	$ 1.01 B	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	8.53 M	-	-18.52 %	$ 27.3 M	Britain
Aptorum Group Limited APM	3.5 M	$ 0.91	1.61 %	$ 6.69 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	320 M	$ 22.3	1.55 %	$ 3.7 B	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	66.4 M	-	-	$ 28.6 M	USA
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	7.31 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	29 K	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	49.9 M	-	-	$ 8.42 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	4.88 M	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	7.68 B	$ 102.42	-2.88 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	2.86 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	121 M	$ 4.13	1.1 %	$ 442 M	USA
Arcutis Biotherapeutics ARQT	42.9 M	$ 23.34	0.32 %	$ 2.97 B	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	104 M	$ 1.43	-0.69 %	$ 381 M	Britain
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	5.71 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 2.9	-0.34 %	$ 4.77 M	Israel
Esperion Therapeutics ESPR	168 M	$ 1.92	0.54 %	$ 399 M	USA
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
bluebird bio BLUE	222 M	-	-	$ 546 M	USA
ContraFect Corporation CFRX	8.91 M	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	17.5 M	$ 1.72	-	$ 115 M	USA
BioXcel Therapeutics BTAI	28.4 M	$ 1.09	1.89 %	$ 13.3 M	USA
Cabaletta Bio CABA	83 M	$ 2.95	-0.17 %	$ 296 M	USA
Cara Therapeutics CARA	20.7 M	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	38.7 M	-	-	$ 35.4 M	USA